Skip to main content
Equasens logo

Equasens — Investor Relations & Filings

Ticker · EQS ISIN · FR0012882389 LEI · 96950066I7XVFGZI8L92 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2025-11-05 Earnings Release
Country FR France
Listing PA EQS

About Equasens

https://equasens.com

Equasens is a company specializing in healthcare IT solutions for professionals and establishments. It develops and provides a range of products including professional software, electronic equipment, connected devices, and digital health solutions. The company's offerings cater to a diverse client base, including pharmacies, hospitals, nursing homes (EHPADs), home care services, and independent medical practitioners. The primary objective of its solutions is to improve the quality of patient care by facilitating the secure sharing of health data, enhancing communication between different care providers, and optimizing the coordination of care pathways across outpatient, hospital, and home care settings.

Recent filings

Filing Released Lang Actions
EQUASENS : Chiffre d'affaires au 30 septembre 2025
Earnings Release Classification · 96% confidence The document is a financial press release from Groupe Equasens detailing their revenue (chiffre d'affaires) for the period ending September 30, 2025. It provides a breakdown of revenue by segment and division, discusses business performance, and outlines future outlooks. It is not a full annual report (10-K) or an interim report (IR) in the sense of a full financial statement package, but rather an initial announcement of periodic financial results. According to the definitions, this fits the 'Earnings Release' (ER) category as it focuses on key financial highlights for a specific period. 9M 2025
2025-11-05 French
EQUASENS : Mise à disposition du rapport financier semestriel 2025
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2813 characters) stating that the company's half-year financial report has been published and filed with the AMF. It provides links to where the report can be accessed rather than containing the financial report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2025-09-30 French
EQUASENS : Rapport financier semestriel 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Rapport Financier Semestriel 2025' (Interim Financial Report 2025) for the period ending June 30, 2025. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow statement, as well as notes to the accounts. It is not a mere announcement or certification, but the full interim report itself, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-09-30 French
EQUASENS : Bilan S1 2025 contrat de liquidité
Transaction in Own Shares Classification · 95% confidence The document is a 'Bilan Semestriel' (Half-Year Report) regarding a liquidity contract ('contrat de liquidité') for the company EQUASENS. It details the number of shares and cash balance held in the liquidity account as of June 30, 2025, and provides a detailed table of daily transactions (purchases and sales) conducted by the liquidity provider (Gilbert Dupont) during the first half of 2025. This type of disclosure is a standard regulatory requirement for companies listed on Euronext Paris to report on their share buyback/liquidity programs. Among the provided categories, 'Transaction in Own Shares' (POS) is the most accurate classification as it specifically covers reports of companies buying back or selling their own shares through liquidity providers.
2025-09-29 French
Equasens: 2025 half-year results
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive report detailing the '2025 half-year results' for the Equasens Group. It includes detailed financial tables (Revenue, EBITDA, Net Profit, Balance Sheet), divisional performance analysis, and management commentary on business trends and outlook. It is not an announcement of a report (RPA) because it contains the actual financial data and analysis itself. It is not a full Annual Report (10-K) as it covers only the six-month period ending 30 June 2025. Therefore, it is classified as an Interim/Quarterly Report. H1 2025
2025-09-26 English
EQUASENS : Résultats semestriels 2025
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half of 2025 ('Résultats semestriels 2025'). It contains detailed financial statements, including income statements, balance sheet highlights, divisional performance analysis (Pharmagest, Axigate Link, etc.), and management commentary on business trends and outlook. It is not a short announcement or a certification, but the actual interim financial report. Therefore, it is classified as an Interim / Quarterly Report. H1 2025
2025-09-26 French

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.